Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry (Q37559395)

21 August 2017

1 reference

title

Deferoxamine therapy and mucormycosis in dialysis patients: report of an international registry (English)

1 reference

21 August 2017

0 references

0 references

1 reference

Boelaert JR

1

1 reference

PubMed ID

1962650

21 August 2017

Fenves AZ

series ordinal

2

1 reference

PubMed ID

1962650

21 August 2017

Coburn JW

series ordinal

3

1 reference

21 August 2017

1 December 1991

1 reference

21 August 2017

8

1 reference

American Journal of Kidney Diseases

inferred from page(s)

published in

1 reference

21 August 2017

18

1 reference

21 August 2017

6

1 reference

21 August 2017

660-667

1 reference

Intestinal mucormycosis in hemodialysis patients following deferoxamine

21 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Mucormycosis--a new risk of deferoxamine therapy in dialysis patients with aluminum or iron overload?

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Disseminated zygomycosis: report of four cases and review

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Myocardial mucormycosis with emboli in a hemodialysis patient.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Myocardial mucormycosis with emboli in a hemodialysis patient

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Fatal fungal peritonitis in an adolescent on continuous ambulatory peritoneal dialysis: association with deferoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Fatal phycomycosis in a hemodialyzed patient receiving deferoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Mucormycosis in deferoxamine-treated patients on dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Fatal Rhizopus infections in hemodialysis patients receiving deferoxamine

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

[Mucormycosis in a hemodialysis patient with iron overload]

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Mucormycotic slough of nasal floor and palate in the anephric patient

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Peritoneal mucormycosis in a patient receiving continuous ambulatory peritoneal dialysis

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Nosocomial Clostridium difficile infections

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Registry on mucormycosis in dialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Death risk in hemodialysis patients: the predictive value of commonly measured variables and an evaluation of death rate differences between facilities

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Phycomycosis complicating leukemia and lymphoma.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

1 reference

7 January 2021

Kidney disease of diabetes mellitus: NIDDK initiatives for the comprehensive study of its natural history, pathogenesis, and prevention

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Effects of deferoxamine, feroxamine and iron on experimental mucormycosis (zygomycosis).

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Effects of iron and desferrioxamine on Rhizopus infection.

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Mucormycosis: association with deferoxamine therapy

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Dealing with uncertainty, risks, and tradeoffs in clinical decisions. A cognitive science approach

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

A mechanism of susceptibility to mucormycosis in diabetic ketoacidosis: transferrin and iron availability

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Deferoxamine does not increase the risk for bacteremia in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

The role of iron overload in Yersinia enterocolitica and Yersinia pseudotuberculosis bacteremia in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Cutaneous Phycomycosis (Mucormycosis) With Fatal Pulmonary Dissemination

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Mucormycosis in patients with renal failure

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Rapid removal of DFO-chelated aluminum during hemodialysis using polysulfone dialyzers

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

Accelerated removal of deferoxamine mesylate-chelated aluminum by charcoal hemoperfusion in hemodialysis patients

1 reference

https://api.crossref.org/works/10.1016%2FS0272-6386%2812%2980606-8

7 January 2021

10.1016/S0272-6386(12)80606-8

Identifiers

DOI

1 reference

21 August 2017

1 reference

PubMed ID

1962650